CHMMF vs GILD: Which Stock is Better?
Side-by-side comparison of Chimeric Therapeutics Limited and Gilead Sciences Inc in 2026
CHMMF
Chimeric Therapeutics Limited
$0.00
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | CHMMF | GILD | Winner |
|---|---|---|---|
| Market Cap | $4.42M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | -0.5% | 0.0% | GILD |
| Gross Margin | 91.3% | 78.8% | CHMMF |
Analyze CHMMF
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHMMF or GILD a better investment?
Comparing CHMMF and GILD: Chimeric Therapeutics Limited has a market cap of $4.42M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHMMF and GILD?
CHMMF (Chimeric Therapeutics Limited) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHMMF or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHMMF or GILD?
GILD has higher revenue growth at 0.0% vs -0.5% for CHMMF.
Which company is more profitable: CHMMF or GILD?
Chimeric Therapeutics Limited (CHMMF) has higher gross margins at 91.3% compared to 78.8% for GILD.
Which is the larger company: CHMMF or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $4.42M for CHMMF.
Should I buy CHMMF or GILD in 2026?
Both CHMMF and GILD have investment merit. CHMMF trades at $0.00 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHMMF and GILD stock?
Key differences: Market Cap ($4.42M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (-0.5% vs 0.0%), Gross Margin (91.3% vs 78.8%).